RSLS Net Margin
As of 2025-05-16, the Net Margin of ReShape Lifesciences Inc (RSLS) is -89.1%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
RSLS Net Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | -89.1% |
| 2023-12-31 | -131.2% |
| 2022-12-31 | -411.1% |
| 2021-12-31 | -464.3% |
| 2020-12-31 | -775.5% |
| 2019-12-31 | -721.9% |
| 2018-12-31 | -410.8% |
| 2017-12-31 | -350.9% |
| 2016-12-31 | -603.8% |
| 2015-12-31 | -385.2% |
RSLS Net Margin - Peers Comparison